Clinical Trial Update: Talc in Treating Patients With Malignant Pleural Effusion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating talc pleurodesis for malignant pleural effusion has completed enrollment with status shown as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion

Drugs mentioned

• Talc (talc)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Metastatic Cancer | Phase 3 | Status: COMPLETED